Inaccurate Life Expectancy in CA Not Usually From Medical Source

This article originally appeared here.
Share this content:
Inaccurate Life Expectancy in CA Not Usually From Medical Source
Inaccurate Life Expectancy in CA Not Usually From Medical Source

FRIDAY, April 1, 2016 (HealthDay News) -- Most patients with advanced cancer are inaccurate in their life expectancy estimates (LEEs), and the source of that information typically is not a medical provider, according to a study published online March 29 in Cancer.

Kelly M. Trevino, Ph.D., from the Cornell Center for Research on End-of-Life Care in New York City, and colleagues conducted a prospective, longitudinal, multisite study of terminally ill cancer patients. Two hundred twenty-nine patients (31 black and 198 white) reported their LEEs in structured interviews and the source of these estimates. LEE accuracy was calculated through comparison of patients' self-reported LEEs with actual survival.

The researchers found that 39.3 percent of patients estimated their life expectancy to within 12 months of survival. An inaccurate LEE was more likely among black than white patients. A minority of patients reported that the source of their LEE was a medical provider (18.3 percent [0 percent among blacks]). After adjustment for sociodemographic characteristics and the source of LEEs, black race remained a significant predictor of an inaccurate LEE.

"The majority of advanced cancer patients have an inaccurate understanding of their life expectancy," the authors write. "Medical providers are not the source of information for LEEs for most advanced cancer patients and especially for black patients."

One author is employed by Johnson & Johnson.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »